Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Haemonetics Stock Fell 13% Today


Investors were not kind to Haemonetics (NYSE: HAE) on Thursday, trading the stock down by more than 13%. The sell-off occurred in the wake of the blood and plasma collection systems company's 2021 earnings release for the fiscal fourth quarter of 2021.

The quarter saw Haemonetics earn $221 million in revenue, down 6% on a year-over-year basis. Non-GAAP (adjusted) net income also went south, declining by almost 33% to $23.9 million, or $0.46.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
HAE
Share

Comments